574 related articles for article (PubMed ID: 25688160)
21. CD3+ and CD8+ T cell-based immune cell score as a prognostic factor in clear-cell renal cell carcinoma.
Åkerla J; Helminen O; Väyrynen JP; Parkkinen A; Järvenpää H; Böhm J; Ahtiainen M; Seikkula H
Acta Oncol; 2024 Mar; 63():105-110. PubMed ID: 38578213
[TBL] [Abstract][Full Text] [Related]
22. Genomic Landscape of Chinese Clear Cell Renal Cell Carcinoma Patients With Venous Tumor Thrombus Identifies Chromosome 9 and 14 Deletions and Related Immunosuppressive Microenvironment.
Niu S; Liu K; Xu Y; Peng C; Yu Y; Huang Q; Wu S; Cui B; Huang Y; Ma X; Zhang X; Wang B
Front Oncol; 2021; 11():646338. PubMed ID: 34249685
[TBL] [Abstract][Full Text] [Related]
23. Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery.
Shapiro DD; Lozar T; Cheng L; Xie E; Laklouk I; Lee MH; Huang W; Jarrard DF; Allen GO; Hu R; Kinoshita T; Esbona K; Lambert PF; Capitini CM; Kendziorski C; Abel EJ
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339231
[TBL] [Abstract][Full Text] [Related]
24. Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma.
Xu W; Lu J; Tian X; Ye S; Wei S; Wang J; Anwaier A; Qu Y; Liu W; Chang K; Zhang H; Ye D
MedComm (2020); 2024 Jan; 5(1):e461. PubMed ID: 38222314
[TBL] [Abstract][Full Text] [Related]
25. Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.
Su DG; Schoenfeld DA; Ibrahim W; Cabrejo R; Djureinovic D; Baumann R; Rimm DL; Khan SA; Halaban R; Kluger HM; Olino K; Galan A; Clune J
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519058
[TBL] [Abstract][Full Text] [Related]
26. Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules.
Kawashima A; Kanazawa T; Goto K; Matsumoto M; Morimoto-Okazawa A; Iwahori K; Ujike T; Nagahara A; Fujita K; Uemura M; Nonomura N; Wada H
Cancer Immunol Immunother; 2018 Jan; 67(1):113-125. PubMed ID: 28975380
[TBL] [Abstract][Full Text] [Related]
27. The Novel Checkpoint Target Lymphocyte-Activation Gene 3 Is Highly Expressed in Cutaneous Squamous Cell Carcinoma.
Dany M; Doudican N; Carucci J
Dermatol Surg; 2023 Dec; 49(12):1112-1115. PubMed ID: 37962130
[TBL] [Abstract][Full Text] [Related]
28. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy.
Krishna C; DiNatale RG; Kuo F; Srivastava RM; Vuong L; Chowell D; Gupta S; Vanderbilt C; Purohit TA; Liu M; Kansler E; Nixon BG; Chen YB; Makarov V; Blum KA; Attalla K; Weng S; Salmans ML; Golkaram M; Liu L; Zhang S; Vijayaraghavan R; Pawlowski T; Reuter V; Carlo MI; Voss MH; Coleman J; Russo P; Motzer RJ; Li MO; Leslie CS; Chan TA; Hakimi AA
Cancer Cell; 2021 May; 39(5):662-677.e6. PubMed ID: 33861994
[TBL] [Abstract][Full Text] [Related]
29. Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases.
Ye J; Guo W; Wang C; Egelston CA; D'Apuzzo M; Shankar G; Fakih MG; Lee PP
Cancer Res Commun; 2023 Oct; 3(10):2082-2095. PubMed ID: 37768208
[TBL] [Abstract][Full Text] [Related]
30. High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints.
Raghubar AM; Matigian NA; Crawford J; Francis L; Ellis R; Healy HG; Kassianos AJ; Ng MSY; Roberts MJ; Wood S; Mallett AJ
NPJ Precis Oncol; 2023 Sep; 7(1):88. PubMed ID: 37696903
[TBL] [Abstract][Full Text] [Related]
31. Genomic and immunologic correlates of LAG-3 expression in cancer.
Panda A; Rosenfeld JA; Singer EA; Bhanot G; Ganesan S
Oncoimmunology; 2020 May; 9(1):1756116. PubMed ID: 32923111
[TBL] [Abstract][Full Text] [Related]
32. Post-transplant Malignancies Show Reduced T-cell Abundance and Tertiary Lymphoid Structures as Correlates of Impaired Cancer Immunosurveillance.
Datta RR; Schran S; Persa OD; Aguilar C; Thelen M; Lehmann J; Garcia-Marquez MA; Wennhold K; Preugszat E; Zentis P; von Bergwelt-Baildon MS; Quaas A; Bruns CJ; Kurschat C; Mauch C; Löser H; Stippel DL; Schlößer HA
Clin Cancer Res; 2022 Apr; 28(8):1712-1723. PubMed ID: 35191474
[TBL] [Abstract][Full Text] [Related]
33. YTHDF3 phase separation regulates HSPA13-dependent clear cell renal cell carcinoma development and immune evasion.
Dai C; Cao J; Tang Y; Jiang Y; Luo C; Zheng J
Cancer Sci; 2024 May; ():. PubMed ID: 38811341
[TBL] [Abstract][Full Text] [Related]
34. Understanding Factors that Influence Prognosis and Response to Therapy in Clear Cell Renal Cell Carcinoma.
Jia L; Cowell LG; Kapur P
Adv Anat Pathol; 2024 Mar; 31(2):96-104. PubMed ID: 38179997
[TBL] [Abstract][Full Text] [Related]
35. The utilization of single-cell sequencing technology in investigating the immune microenvironment of ccRCC.
Liu Y; Wu G
Front Immunol; 2023; 14():1276658. PubMed ID: 38090562
[TBL] [Abstract][Full Text] [Related]
36. Letter comments on: Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma.
Rebuzzi SE; Fornarini G; Banna GL; Rescigno P; Buti S
Eur J Cancer; 2024 Jul; 205():114097. PubMed ID: 38735162
[No Abstract] [Full Text] [Related]
37. Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology.
Kang BW; Kim JG; Lee IH; Bae HI; Seo AN
World J Gastrointest Oncol; 2017 Jul; 9(7):293-299. PubMed ID: 28808502
[TBL] [Abstract][Full Text] [Related]
38. Retraction Note: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model.
Barshidi A; Karpisheh V; Noukabadi FK; Kiani FK; Mohammadi M; Afsharimanesh N; Ebrahimi F; Kiaie SH; Navashenaq JG; Hojjat-Farsangi M; Zolbanin NM; Mahmoodpoor A; Hassannia H; Nami S; Jalali P; Jafari R; Jadidi-Niaragh F
Pharm Res; 2024 Feb; 41(2):407-408. PubMed ID: 38148385
[No Abstract] [Full Text] [Related]
39. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
40. Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.
Becht E; Giraldo NA; Germain C; de Reyniès A; Laurent-Puig P; Zucman-Rossi J; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
Adv Immunol; 2016; 130():95-190. PubMed ID: 26923001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
